QGN — Lateral Flow Immunochromatography Assay For Host Infection Biomarkers Class II

FDA Device Classification

FDA product code QGN covers "Lateral Flow Immunochromatography Assay For Host Infection Biomarkers", a Class II medical device regulated under 21 CFR 866.3230. Submissions are reviewed by the Microbiology panel. At least 2 recent 510(k) clearances have been granted under this product code.

Classification Details

Product Code
QGN
Device Class
Class II
Regulation Number
866.3230
Submission Type
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

A device to detect and measure non-microbial analytes to aid in the detection and identification of localized human infections is identified as an in vitro device intended for the detection and qualitative measurement, quantitative measurement, or both of one or more non-microbial analytes in human clinical specimens to aid in the assessment, identification, or both of a localized microbial infection when used in conjunction with clinical signs and symptoms and other clinical and laboratory findings.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K212204cd diagnosticsSynovasure Alpha Defensin Lateral Flow Test Kit (1 Kit), Synovasure Alpha DefensAugust 11, 2021
DEN180032cd diagnosticsSynovasure Alpha Defensin Lateral Flow Test Kit, Synovasure Alpha Defensin LaterMay 23, 2019